A NOTE ON THE SELECTION OF CONTROL-GROUPS AND CONTROL VARIABLES IN COMORBIDITY RESEARCH

被引:21
作者
ALLISON, DB
机构
[1] Obesity Research Center, Saint Luke's/Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, NY
关键词
D O I
10.1016/0010-440X(93)90020-5
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Recently, investigators have become interested in "comorbidity" in eating disorders (EDs). However, it appears that many investigators fail to appreciate that demonstrating that ED patients have more of a given type of concomitant psychopathology than would be expected by chance requires the rejection of the following two null hupotheses: H0-1, Persons with EDs have no more symptomatology of the putatively comorbid condition than do persons without EDs; and H0-2, Persons with EDs have no more symptomatology of the putatively comorbid condition than they have other kinds of psychopathology not specific to ED. The choice of proper control group for testing H0-1 and the necessity of testing H0-2 are illustrated with simulated data. These same general issues apply to the assessment of comorbidity in other conditions, but the appropriate comparison group obviously changes according to the exact hypothesis being tested. © 1993.
引用
收藏
页码:336 / 339
页数:4
相关论文
共 9 条
[1]  
BEIDEL DC, 1991, NOV ANN M ASS ADV BE
[2]  
BRADLEY DR, 1989, DATASIM
[3]  
BULIK CM, 1991, NOV ANN M ASS ADV BE
[4]  
HALMI KA, 1991, ARCH GEN PSYCHIAT, V48, P712
[5]   EATING DISORDERS - A PRIMER FOR THE SUBSTANCE-ABUSE SPECIALIST .1. CLINICAL-FEATURES [J].
KATZ, JL .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1990, 7 (03) :143-149
[6]  
PIGOTT T, 1991, NOV ANN M ASS ADV BE
[7]  
RUSSELL G, 1990, 4TH INT C EAT DIS NE
[8]  
YATES WR, 1989, J CLIN PSYCHIAT, V50, P57
[9]  
ZANARINI MC, 1990, COMPR PSYCHIAT, V30, P20